Findings of <scp> <sup>18</sup> F‐PI </scp> ‐2620 tau <scp>PET</scp> imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample-Reference-Cited by-同舟云学术

Findings of ¹⁸ F‐PI ‐2620 tau PET imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample

Published:2022-07-17 Issue:4 Volume:42 Page:437-448
ISSN:2574-173X
Container-title:Neuropsychopharmacology Reports
language:en
Short-container-title:Neuropsychopharm Rep

Author:

Bun Shogyoku¹^ORCID,Moriguchi Sho¹,Tezuka Toshiki²,Sato Yoshiaki³,Takahata Keisuke¹⁴,Seki Morinobu²,Nakajima Shinichiro¹,Yamamoto Yasuharu¹⁴,Sano Yasunori¹⁴,Suzuki Natsumi¹,Morimoto Ayaka¹,Ueda Ryo⁵,Tabuchi Hajime¹,Ito Daisuke²,Mimura Masaru¹

Affiliation:

1. Department of Neuropsychiatry Keio University School of Medicine Tokyo Japan

2. Department of Neurology Keio University School of Medicine Tokyo Japan

3. Eisai‐Keio Innovation Laboratory for Dementia hhcData Creation Center Eisai Co., Ltd. Tokyo Japan

4. Department of Functional Brain Imaging Research, National Institute of Radiological Sciences National Institutes for Quantum and Radiological Science and Technology Chiba Japan

5. Office of Radiation Technology Keio University Hospital Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12281

Reference36 articles.

1. Amyloid-β-independent regulators of tau pathology in Alzheimer disease

2. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease